BioNTech selects Rwanda, Senegal for potential malaria and tuberculosis mRNA vaccine manufacturing

BioNTech selects Rwanda, Senegal for potential malaria and tuberculosis mRNA vaccine manufacturing
nhigginsdunn
Fri, 08/27/2021 – 08:55